scout
Opinion|Videos|January 3, 2024

Ocular Toxicity Management Strategies for Patients With Cervical Cancer Receiving ADCs

Experts detail the management of ocular toxicity associated with tisotumab vedotin in patients with cervical cancer, emphasizing the need for eye care professionals and a team approach, along with addressing peripheral neuropathy.

Episodes in this series

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME